Align Technology (WBO:ALGN) EBITDA Margin % : 18.76% (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Align Technology EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Align Technology's EBITDA for the three months ended in Mar. 2024 was €172 Mil. Align Technology's Revenue for the three months ended in Mar. 2024 was €918 Mil. Therefore, Align Technology's EBITDA margin for the quarter that ended in Mar. 2024 was 18.76%.

Align Technology EBITDA Margin % Historical Data

The historical data trend for Align Technology's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Align Technology EBITDA Margin % Chart

Align Technology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBITDA Margin %

Get a 7-Day Free Trial

24.66

19.45

27.45

20.88

20.69

Align Technology Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBITDA Margin %	Get a 7-Day Free Trial															17.95	20.73	21.18	22.85	18.76

Competitive Comparison of Align Technology's EBITDA Margin %

For the Medical Devices subindustry, Align Technology's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Align Technology's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Align Technology's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Align Technology's EBITDA Margin % falls into.

Align Technology EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Align Technology's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	732.733	/	3541.692
	=	20.69 %

Align Technology's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %	=	EBITDA (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	172.115	/	917.637
	=	18.76 %

Align Technology (WBO:ALGN) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Align Technology EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Align Technology's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Align Technology (WBO:ALGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Align Technology Inc (WBO:ALGN) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

ALGN:USA ALGN:Mexico AFW:Germany A1LG34:Brazil

Address

410 North Scottsdale Road, Suite 1300, Tempe, AZ, USA, 85281

Website

https://www.aligntech.com

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the FDA in 1998, and it has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans and iTero scans make up over half of these scans.